1882 Inorganic Chemistry, Vol. 49, No. 4, 2010
Guenet et al.
(m, 4H, He1), 3.39-3.44 (m, 4H, He2), 3.58-3.62 (m, 4H, He3),
3.70-3.74 (m, 4H, He4), 4.66 (s, 4H, Hf), 5.31 (dd, 3J=7.2 Hz, 4
J=2.5 Hz, 2H, Hd), 5.49 (t, 3J=8.0 Hz, 2H, Hc), 7.40 (d, 3J=
7.8 Hz, 2H, Hg), 7.76 (t, 3J=7.8 Hz, 1H, Hh), 7.82-7.92 (m, 9H,
Hi,J), 8.10-8.16 (m, 2H, Hm), 8.17 -8.22 (m, 6H, Hk), 9.02 (d,
3J=5 Hz, 2H, HL4), 9.03 (m, 2H, Hn), 9.07 (s, 4H, HL1,L2), 9.07
(d, 3J=6.5 Hz, 2H, HL3). 13C NMR (CD3CN/CD2Cl2 8/2, 100
MHz): δ (assignments according to HSQC and HMBC 2D
1H-13C NMR experiments) 66.4 (Ce1), 69.0 (Ce2), 70.1 (Ce4),
70.8 (Ce3), 74.1 (Cf), 102.7 (Ca), 103.0 (Cd), 109.8 (Cb), 118.4
(Cp), 120.1 (Cg), 122.4 (Cs,w), 126.4 (Cc), 127.0 (Ck), 128.5 (CJ),
129.3 (Cm), 131.8 (CL4), 132.8 (CL1,L2), 133.0 (CL3), 134.6 (Ci),
137.1 (Ch), 140.5 (Ct,x), 146.2 (Cq), 147.1 (Cr,u,v), 147.2 (Co),
148.4 (Cn), 155.7 (Ca1), 157.4 (Ca2), 158.3 (Cg1). UV-vis
(CH2Cl2) λ max (nm) (ε, mol-1 L cm-1) 424 (2.2 ꢀ 105), 560
(1.5 ꢀ 104), 600 (0.8 ꢀ 104) MALDI-TOF MS: m/z obsd
1231.30, calcd 1231.34 [(M-H) þ; M=C70H58N6O8Sn].
max (nm) (ε, mol-1 L cm-1) 425 (3.0 ꢀ 105), 561 (1.9 ꢀ 104), 601
(1.1 ꢀ 104). MALDI-TOF MS: m/z obsd 1230.31, calcd 1230.34
[(MþH)þ; M=C71H59N5O8Sn].
Compound 5. To a solution of 7 (6.1 mg, 0.013 mmol, 1 equiv)
in dichloromethane (5 mL) was added 33 (10 mg, 0.013 mmol, 1
equiv). The resulting solution was stirred at RT for 4 days. After
removal of the solvent, a violet powder was obtained which was
recrystallized in a mixture of toluene/n-hexane (12.2 mg, 78%).
1H NMR (CD2Cl2, 400 MHz): δ (assignments according to
COSY and ROESY 2D 1H-1H NMR experiments) 1.28 (t, 4J=
2.3 Hz, 2H, Ha), 1.53 (ddd, 3J=8.0 Hz, 4J=2.0 Hz, 4J=0.9 Hz,
2H, Hb), 3.14-3.16 (m, 4H, He1), 3.49-3.51 (m, 4H, He2),
3.60-3.63 (m, 4H, He3), 3.66-3.69 (m, 4H, He4), 3.71 (s, 8H,
H
e5,e6), 5.38 (ddd, 3J=8.0 Hz, 4J=2.3 Hz, 4J=0.8 Hz, 2H, Hd),
5.55 (t, 3J=8.0 Hz, 2H), 7.86-7.93 (m, 9H, Hi,J), 8.19 (dd, 3J=
4.2 Hz, 4J=1.5 Hz, 2H, Hm,), 8.27-8.29 (m, 3H, Hk), 9.11 (dd,
3J=3.6 Hz, 4J=1.2 Hz, 2H, Hn), 9.14 (d, 3J=4.8 Hz, 2H, HL3),
9.21 (s, 4H, HL1,L2), 9.23 (d, 3J=4.8 Hz, 2H, HL4). 13C NMR
(CD2Cl2, 100 MHz): δ (assignments according to HSQC and
HMBC 2D 1H-13C NMR experiments) 66.6 (Ce1), 69.5 (Ce2),
71.0 (Ce3,e4,e5,e6), 103.3 (Ca), 104.2 (Cd), 110.5 (Cb), 118.2 (Cp),
126.7 (Cc), 126.9 (Cs,w), 127.5 (Ci), 128.8 (CJ), 129.6 (Cm), 131.6
(Cq), 132.0 (CL3), 132.6 (CL1,L2), 132.8 (CL4), 135.0 (Ck), 140.5
(Ct,x), 146.1 (Cr), 147.2 (Cu,v), 148.5 (Co), 148.9 (Cn), 155.6 (Ca2),
Compound 3. To a solution of 32 (24.0 mg, 0.031 mmol, 1
equiv) in dry chloroform (10 mL) was added dropwise under
argon a solution of 9 (20.0 mg, 0.034 mmol, 1.1 equiv) in dry
chloroform (20 mL). The resulting mixture was stirred at RT
1
during 6 days. The reaction was monitored by H NMR. The
solvent was removed in vacuo. The resulting powder was
recrystallized by slow diffusion of n-hexane into a toluene
solution of 3 to afford a crystalline violet powder (40.0 mg,
96%). Single crystals suitable for X-ray diffraction were grown
by vapor diffusion of n-hexane into a toluene solution contain-
ing the desired compound. 1H NMR (CDCl3, 300 MHz): δ 1.38
(t, 4J=2.2 Hz, 2H, CHres), 1.53 (dd, 3J=7.7 Hz, 4J=2.1 Hz, 2H,
CHres), 3.16 (t, 3J=5.0 Hz, 4H, CH2O), 3.49 (t, 3J=5.0 Hz, 4H,
CH2O), 3.59 (m, 4H, CH2O), 3.64 (m, 4H, CH2O), 3.76 (m, 8H,
CH2O), 4.74 (s, 4H, ArCH2), 5.38 (dd, 3J=8.1 Hz, 4J=2.2 Hz,
2H, CHres), 5.53 (t, 3J = 8.0 Hz, 2H, CHres), 7.34 (d, 3J =
157.1 (Ca1). UV-vis (CH2Cl2) λ max (nm) (ε, mol-1 L cm-1
)
425 (2.0 ꢀ 105), 560 (1.3 ꢀ 104), 600 (0.7 ꢀ 104). MALDI-TOF
MS: m/z obsd 1198.17, calcd 1198.34 [(MþHþ); M =
C67H59N5O9Sn].
Compound 6. To a solution of 32 (50.2 mg, 0.066 mmol, 1
equiv) in dry chloroform (20 mL) was added dropwise under
argon a solution of 7 (33.8 mg, 0.073 mmol, 1.1 equiv) in dry
chloroform (30 mL). The resulting mixture was stirred at RT
during 5 days. The reaction was monitored by 1H NMR. After
removal of the solvent, the resulting powder was recrystallized
by slow diffusion of n-hexane into a toluene solution of 6
affording a crystalline dark red powder (68.3 mg, 85%). Single
crystals suitable for X-ray diffraction were grown by vapor
diffusion of n-hexane into a toluene solution containing the
compound. 1H NMR (CDCl3, 300 MHz): δ 1.35 (t, 4J=2.1 Hz,
2H, CHres), 1.59 (dd, 3J=7.7 Hz, 4J=2.0 Hz, 2H, CHres), 3.15 (t,
3J = 4.9 Hz, 4H, CH2O), 3.50 (t, 3J = 4.9 Hz, 4H, CH2O),
3.59-3.74 (m, 16H, CH2O), 5.39 (dd, 3J=7.9 Hz, 4J=2.2 Hz,
2H, CHres), 5.53 (t, 3J = 8.0 Hz, 2H, CHres), 7.78-7.86 (m,
12H, CHPh meta/para), 8.21-8.24 (m, 8H, CHPh ortho), 9.11 (s, 8H,
CHβ-pyrrolic, 4JSn-H=12.4 Hz). 13C NMR (CDCl3, 75 MHz): δ
66.3 (CH2O), 69.5 (CH2O), 70.6 (2ꢀCH2O), 70.9 (CH2O), 71.0
(CH2O), 103.2 (CH), 103.6 (CH), 110.4 (CH), 121.8 (Cquat),
126.3 (CH), 127.0 (CH), 128.3 (CH), 132.6 (CH), 134.9 (CH),
141.0 (Cquat), 147.3 (Cquat). UV-vis (CH2Cl2) λ max (nm) (ε,
mol-1 L cm-1) 425 (2.7 ꢀ 105), 561 (1.6 ꢀ 104), 600 (0.9 ꢀ 104).
3
7.5 Hz, 2H, CHPy), 7.42 (t, J=7.7 Hz, 1H, CHPy), 7.78 (m,
12H, CHPh meta/para), 8.19 (m, 8H, CHPh ortho), 9.07 (s, 8H,
CHβ-pyrrolic, 4JSn-H=12.6 Hz). 13C NMR (CDCl3, 75 MHz): δ
66.2 (CH2O), 69.6 (CH2O), 70.5 (CH2O), 70.7 (CH2O), 70.8
(CH2O), 70.9 (CH2O), 74.2 (CH2O), 103.2 (CH), 103.7 (CH),
110.4 (CH), 120.1 (CH), 121.8 (Cquat), 126.3 (CH), 126.9 (CH),
128.3 (CH), 132.5 (CH), 134.9 (CH), 137.2 (CH), 141.0 (Cquat),
147.2 (Cquat), 155.8 (Cquat), 157.0 (Cquat), 158.0 (Cquat). UV-vis
(CH2Cl2) λ max (nm) (ε, mol-1 L cm-1) 425 (3.2 ꢀ 105), 561
(2.0 ꢀ 104), 600 (1.3 ꢀ 104). Anal. Calcd. for C75H67N5O10Sn: C,
68.39; H, 5.13; N, 5.32. Found: C, 68.28; H, 5.11; N, 5.30.
MALDI-TOF MS: m/z obsd 1318.36, calcd 1318.19 [(MþH)þ;
M=C75H67N5O10Sn].
Compound 4. To a solution of 32 (42.1 mg, 0.055 mmol, 1
equiv) in dry chloroform (18 mL) was added dropwise under
argon a solution of 8 (30.2 mg, 0.060 mmol, 1.1 equiv) in dry
chloroform (34 mL). The resulting mixture was stirred at RT
during 4 days. The reaction was monitored by 1H NMR. After
removal of the solvent, the resulting powder was recrystallized
by slow diffusion of n-hexane into a toluene solution of 4
affording a crystalline dark red powder (62 mg, 92%). Single
crystals suitable for X-ray diffraction were grown by vapor
diffusion of n-hexane into a toluene solution containing the
compound. 1H NMR (CDCl3, 300 MHz): δ 1.33 (t, 4J=2.3 Hz,
2H, CHres), 1.55 (dd, 3J=7.9 Hz, 4J=1.8 Hz, 2H, CHres), 3.15
(m, 4H, CH2O), 3.48 (m, 4H, CH2O), 3.65 (m, 4H, CH2O), 3.75
(m, 4H, CH2O), 4.76 (s, 4H, ArCH2), 5.35 (ddd, 3J=8.0 Hz, 4J=
2.4 Hz, 4J=0.9 Hz, 2H, CHres), 5.51 (t, 3J=8.0 Hz, 2H, CHres),
7.45 (d, 3J=7.6 Hz, 2H, CHPy), 7.70 (t, 3J=7.6 Hz, 1H, CHPy),
7.78 (m, 12H, CHPh meta/para), 8.20 (m, 8H, CHPh ortho), 9.03 (s,
Anal. Calcd. for C68H60N4O9Sn H2O: C, 67.22; H, 5.11; N,
3
4.61. Found: C, 67.29; H, 5.19; N, 4.07. MALDI-TOF MS: m/z
obsd 1197.32, calcd 1197.34 [(MþH)þ; M=C68H60N4O9Sn].
X-ray Crystallography. Data (Tables S1 and S2, see the
Supporting Information) were collected on a Bruker SMART
CCD diffractometer with Mo-KR radiation. The structures
were solved using SHELXS-97 and refined by full matrix least-
squares on F2 using SHELXL-97 with anisotropic thermal
parameters for all non hydrogen atoms. The hydrogen atoms
were introduced at calculated positions and not refined (riding
model).
CCDC 755098-755104 contain the supplementary crystal-
lographic data for compounds 3-4, 6, and 35-38. These data
data_request/cif.
8H, CHβ-pyrrolic,
4JSn-H = 12.4 Hz). 13C NMR (CDCl3, 75
MHz): δ 66.4 (CH2O), 69.4 (CH2O), 70.2 (CH2O), 71.0
(CH2O), 74.4 (CH2O), 103.3 (CH), 110.4 (CH), 120.4 (CH),
121.7 (Cquat), 126.2 (CH), 126.9 (CH),128.2 (CH), 129.0 (CH),
132.4 (CH), 134.9 (CH), 137.2 (CH), 141.0 (Cquat), 147.2 (Cquat),
155.8 (Cquat), 157.0 (Cquat), 158.1 (Cquat). UV-vis (CH2Cl2) λ
ꢀ
Acknowledgment. Universite de Strasbourg, International
Centre for Frontier Research in Chemistry (FRC), Strasbourg,
Institut Universitaire de France, the CNRS, and the Ministry of